/Bio-Techne%20Corp%20sign-by%20JHVEPhoto%20via%20Shutterstock.jpg)
Minneapolis, Minnesota-based Bio-Techne Corporation (TECH) develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company has a market capitalization of $8.1 billion and operates through Protein Sciences, Diagnostics and Spatial Biology segments.
Companies with a market cap between $2 billion and $10 billion are typically referred to as “mid-cap stocks.” Bio-Techne sits comfortably there, with its market cap exceeding this threshold, reflecting its scale, dominance, and market power.